Insider Transactions in Q2 2022 at Enfusion, Inc. (ENFN)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 15
2022
|
Jan Hauser Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,678
+30.26%
|
-
|
|
Jun 15
2022
|
Kathleen De Rose Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,678
+30.26%
|
-
|
|
Jun 15
2022
|
Lawrence E Leibowitz Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,678
+20.11%
|
-
|
|
Jun 15
2022
|
Bronwen Bastone Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
86,339
+35.49%
|
-
|
|
Jun 15
2022
|
Stephen M Dorton Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,142
+5.15%
|
-
|
|
Jun 15
2022
|
Dan Groman Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,339
+5.57%
|
-
|
|
Jun 15
2022
|
Lorelei M. Skillman Chief Mrktg. & Comm. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,071
+10.17%
|
-
|
|
Jun 15
2022
|
Thomas Kim Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,284
+2.29%
|
-
|
|
May 11
2022
|
Oleg Movchan Chief Executive Officer |
BUY
Conversion of derivative security
|
Indirect |
1,401,818
+50.0%
|
-
|